(S)-Aminobutanedioic acid en es it fr

(S)-Aminobutanedioic acid Brand names, (S)-Aminobutanedioic acid Analogs

(S)-Aminobutanedioic acid Brand Names Mixture

  • No information avaliable

(S)-Aminobutanedioic acid Chemical_Formula


(S)-Aminobutanedioic acid RX_link

No information avaliable

(S)-Aminobutanedioic acid fda sheet

(S)-Aminobutanedioic acid msds (material safety sheet)


(S)-Aminobutanedioic acid Synthesis Reference

No information avaliable

(S)-Aminobutanedioic acid Molecular Weight

133.104 g/mol

(S)-Aminobutanedioic acid Melting Point

230 oC

(S)-Aminobutanedioic acid H2O Solubility

4.5 g/l

(S)-Aminobutanedioic acid State


(S)-Aminobutanedioic acid LogP

-0.67 +/- 0.36

(S)-Aminobutanedioic acid Dosage Forms

Capsules and powder

(S)-Aminobutanedioic acid Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

(S)-Aminobutanedioic acid Pharmacology

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

(S)-Aminobutanedioic acid Absorption

Absorbed from the small intestine by an active transport process

(S)-Aminobutanedioic acid side effects and Toxicity

Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.

(S)-Aminobutanedioic acid Patient Information

No information avaliable

(S)-Aminobutanedioic acid Organisms Affected

Humans and other mammals